None listed
Conditions
Interventions
Intervention1: Group D- Dexamethasone group: The test drug will be prepared by adding 8 mg of dexamethasone to normal saline( total volume 50 ml) and this will be given to the patient intravenously
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1.Parturients in established labour with cervical dilation >3cm, with intact or absent membranes and having satisfactory uterine contractions with >50% effacement. 2.Singleton pregnancy with vertex presentation at term, 3.Primigravidaor gravida 2 (previously normal delivered), 4.Age 18 years or above, weight less than 100kg, height 150 cm or more.
Exclusion criteria
Exclusion criteria: 1.Patient refusal, 2.Any fetal anomalies, 3.History of coagulation disorders, 4.Any contraindications to epidural anaesthesia, 5.History of allergy to local anaesthetics, 6.Any obstetric complications (e.g., premature rupture of amniotic membranes,PIH), 7.Systemic and local sepsis, 8.Parturients having multiple pregnancies and premature labour, 9.History of peptic ulcer disease, 10.Known case of uncontrolled diabetes mellitus, and patient who had received dexamethasone in last 7 days for fetal lung maturity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate hourly average consumption of neuraxially administered ropivacaine for duration of epidural labour analgesia.Timepoint: hourly | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Pain score(VAS SCORING), 2.Maternal satisfaction, 3.Sensory and motor block characteristics, 4.Hemodynamic parameters of mother, 5.Fetal heart rate(FHR), 6.Duration of second stage of labor, 7.Mode of delivery, 8.Apgar scores at 1 and 5 min, and 9.Adverse effectsTimepoint: NA | — |
Countries
India
Contacts
Public ContactDR SHOBHA UJWAL
DR SNMC, JODHPUR
Outcome results
None listed